These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21352638)

  • 21. Azelastine and fluticasone nasal spray: any advantage?
    Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding choices in intranasal steroid therapy: summary of a roundtable meeting.
    Blaiss MS; Benninger MS; Fromer L; Gross G; Mabry R; Mahr T; Marple B; Stoloff S
    Allergy Asthma Proc; 2006; 27(3):254-64. PubMed ID: 16913270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical nasal sprays: treatment of allergic rhinitis.
    Kobayashi RH; Kiechel F; Kobayashi AL; Mellion MB
    Am Fam Physician; 1994 Jul; 50(1):151-7, 161-2. PubMed ID: 7517094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
    Berger WE; Prenner B; Turner R; Meltzer EO
    Allergy Asthma Proc; 2013; 34(6):542-50. PubMed ID: 24169063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
    Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate.
    van Drunen C; Meltzer EO; Bachert C; Bousquet J; Fokkens WJ
    Allergy; 2005; 60 Suppl 80():5-19. PubMed ID: 15948774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New intranasal formulations for the treatment of allergic rhinitis.
    Meltzer EO; Bensch GW; Storms WW
    Allergy Asthma Proc; 2014; 35 Suppl 1():S11-9. PubMed ID: 25582157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adults.
    Raphael GD; Berger WE; Prenner BM; Finn AF; Kelley L; Tantry SK
    Curr Med Res Opin; 2013 Oct; 29(10):1329-40. PubMed ID: 23815103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?
    Waddell AN; Patel SK; Toma AG; Maw AR
    J Laryngol Otol; 2003 Nov; 117(11):843-5. PubMed ID: 14670141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile.
    Lightman S; Scadding GK
    Int Arch Allergy Immunol; 2012; 158(4):317-25. PubMed ID: 22488416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis.
    Nayak AS; Ellis MH; Gross GN; Mendelson LM; Schenkel EJ; Lanier BQ; Simpson B; Mullin ME; Smith JA
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):157-62. PubMed ID: 9500747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life.
    Condemi J; Schulz R; Lim J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):533-8. PubMed ID: 10831008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of once daily triamcinolone acetonide aqueous nasal spray in adults with non-allergic and allergic rhinitis.
    Baccioglu Kavut A; Kalpaklıoğlu F
    Allergol Immunopathol (Madr); 2013; 41(6):374-80. PubMed ID: 23031657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
    Blaiss MS
    Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P; Shah A
    Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA; Pickard AS
    Pharmacotherapy; 2007 Jun; 27(6):852-9. PubMed ID: 17542768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic rhinitis: managing the pediatric spectrum.
    Meltzer EO
    Allergy Asthma Proc; 2006; 27(1):2-8. PubMed ID: 16598985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.